Acute Clinical Syndromes and Suspicion of SARS-CoV-2 Infection: The Experience of a Single Romanian Center in the Early Pandemic Period.
Raluca Ecaterina HaligaVictorita SorodocCatalina LionteOvidiu Rusalim PetrisCristina BologaAdorata-Elena ComanLuminita Gina VataGabriela PuhaGabriela DumitrescuOana SirbuAlexandra StoicaAlexandr CeasovschihMihai ConstantinAndreea Nicoleta CatanaElisabeta JabaLaurentiu SorodocPublished in: Medicina (Kaunas, Lithuania) (2021)
Background and Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, patients with chronic diseases suffering exacerbations have required acute medical care. The purpose of our study was to determine useful criteria for the differentiation of patients with acute clinical syndromes and suspicion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Materials and Methods: This was an observational retrospective study, conducted in an internal medicine clinic from April to May 2020. We collected clinical, biological, and computed tomography (CT) data on patients with exacerbations of chronic diseases and clinical suspicion of SARS-CoV-2 infection. Patients with an already-positive real-time reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 on presentation at the emergency department were excluded from our study. Results: Of 253 suspected cases, 20 were laboratory-confirmed as having SARS-CoV-2 infection by RT-PCR, whereas COVID-19 diagnosis was ruled out in the remaining 233. Venous thromboembolism (VTE) correlated significantly with COVID-19 diagnosis in suspected patients, while laboratory markers were not significantly different between the two groups. Of the suspected patients, significantly higher percentages of dry cough, fever, myalgias, sore throat, loss of smell and appetite, and ground-glass opacities (GGOs) on CT were found in SARS-CoV-2-positive individuals. Conclusions: The study demonstrated that, until receiving the result of an RT-PCR test for SARS-CoV-2 (usually 12-24 h), association with VTE as a comorbidity, fever, dry cough, and myalgia as clinical features, and GGO on CT are the main markers for the identification of COVID-19 patients among those suspected with acute clinical syndromes. Our results also provide evidence for doctors not to rely solely on biological markers in the case of suspected SARS-CoV-2 infection in patients with exacerbations of chronic diseases. These data are useful for faster decision-making with regard to suspected COVID-19 patients before receiving RT-PCR test results, thus avoiding keeping patients in crowded emergency departments.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- venous thromboembolism
- computed tomography
- end stage renal disease
- emergency department
- ejection fraction
- pulmonary embolism
- newly diagnosed
- chronic kidney disease
- chronic obstructive pulmonary disease
- contrast enhanced
- liver failure
- peritoneal dialysis
- decision making
- magnetic resonance imaging
- intensive care unit
- patient reported outcomes
- dual energy
- primary care
- artificial intelligence
- direct oral anticoagulants
- atrial fibrillation
- electronic health record